Ignite Creation Date:
2024-05-06 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 12:40 PM
Study NCT ID:
NCT03432364
Status:
COMPLETED
Last Update Posted:
2023-12-14
First Post:
2018-02-01
Brief Title:
A Study to Assess the Safety Tolerability and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia TDT
Sponsor:
Sangamo Therapeutics
Organization:
Sangamo Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-17
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-01
First Submit QC Date:
February 7 2018
Study First Post Date:
2018-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-12-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-12
Last Update Post Date:
2023-12-14
Last Update Post Date Type:
ACTUAL